Johnson & Johnson's McNeil unit will hand over supervision of three manufacturing plans to U.S. health authorities after failing to stem a tide of recalls for products like its Tylenol painkiller. The diversified healthcare company has announced a series of product recalls over the past couple of years. Below are details of those withdrawals.

March 8, 2011
Products: five lots of insulin pump cartridges

Problem: potential leaks

March 2, 2011:
Products: 107 batches of surgical sutures (recalled in December)
Problem: potential sterility problems

Feb.  11, 2011:
Products: 70,000 syringes filled with the antipsychotic drug Invega
Problem: cracks in the syringes

Jan. 14, 2011:
Products: 50 million bottles and packages of various kinds of Tylenol, Benadryl, Rolaids and other consumer products
Problem: lax cleaning procedures at manufacturing plant

Dec. 9, 2010:
Products: All lots of Softchews Rolaids antacids
Problem: wood and metal bits in the tablets

Dec. 2, 2010:
Products: 12 million bottles of Mylanta and almost 85,000 bottles of AlternaGel liquid antacid
Problem: small amounts of alcohol from flavoring agents was not noted on product packaging

Dec.  1, 2010:
Products: 492,000 boxes of 1 Day Acuvue TruEye contact lenses

Problem: consumer complaints of stinging pain

Nov. 24, 2010:
Products: 9 million bottles of Tylenol
Problem: inadequate warning of trace amounts of alcohol used in
the product flavorings

Nov. 23, 2010:
Products: 4 million packages of Children's Benadryl Allergy Fastmelt tablets in cherry and grape flavors, around 800,000 bottles of Junior Strength Motrin Caplets, 71,000 packages of Rolaids, in a cherry flavored extra-strength Softchews formulation
Problem: insufficiencies in the development of the manufacturing process and consumer complaints about consistency and texture

Oct. 18, 2010:
Products: 1 lot of adult Tylenol caplets
Problem: musty or moldy odor

July 8, 2010:
Products: Twenty-one lots of Tylenol for children and adults, several forms of Benadryl and Motrin sold in the United States, Fiji, Guatemala, the Dominican Republic, Puerto Rico, Trinidad and Tobago and Jamaica in expansion of Jan 15 recall. The company has said this action affected 2.5 million bottles of medicines.
Problem: musty or moldy odor detected in earlier recall.

June 15, 2010:
Products: Four lots of Benadryl and Extra Strength Tylenol gels sold in the United States, Trinidad and Tobago, Bermuda and Puerto Rico in expansion of Jan. 15 recall. The company has said 500,000 bottles were affected.
Problem: musty or moldy odor detected in earlier recall.

April 30, 2010:
Products: Forty products including liquid infant and children's pain relievers, Tylenol, and Motrin and allergy medications Zyrtec and Benadryl. About 135 million bottles were affected, according to congressional investigators.
Problem: Manufacturing deficiencies that may have affected the quality, purity or potency of the medicines.

Jan. 15, 2010:
Products: Fifty-three million bottles of over-the-counter products including Tylenol, Motrin and Rolaids, Benadryl and St. Joseph's Aspirin, involving lots in the Americas, the United Arab Emirates and Fiji.
Problem: Unusual moldy, musty or mildew-like odor linked to chemical in wood pallets used to store and ship products.

December 2009:
Product: Expands November recall of Tylenol Arthritis Pain Caplets
Problem: Consumer reports of unusual moldy odor with the 100-count bottles.

November 2009:
Product: Five lots of Tylenol Arthritis Pain Caplets
Problem: Reports of an unusual musty or mildew-like odor that
was associated with nausea, stomach pain, vomiting and diarrhea.

September 2009:
Products: Some lots of infants' and children's Tylenol
Problem: Possible bacterial contamination

July 2009:
Product: Motrin tablets sold mostly at convenience stores. The recall is the subject of a congressional probe into what some Democratic lawmakers say was a stealthy effort to buy back the drug rather than recall it. J&J has said FDA knew of their actions, while FDA has said as soon as it found out, it sought a recall.
Problem: Problems with dissolving

November 2008:
Product: About 12,000 bottles of Mylicon over-the-counter infant anti-gas drops in the dye-free variety. (Sold in a 50-50 joint venture with Merck & Co.
Problem: Bottles may have contained metal fragments.